SA113340494B1 - تركيبة لعلاج اضطرابات أيضية - Google Patents

تركيبة لعلاج اضطرابات أيضية

Info

Publication number
SA113340494B1
SA113340494B1 SA113340494A SA113340494A SA113340494B1 SA 113340494 B1 SA113340494 B1 SA 113340494B1 SA 113340494 A SA113340494 A SA 113340494A SA 113340494 A SA113340494 A SA 113340494A SA 113340494 B1 SA113340494 B1 SA 113340494B1
Authority
SA
Saudi Arabia
Prior art keywords
composition
metabolic disorders
relates
extract
treating metabolic
Prior art date
Application number
SA113340494A
Other languages
Arabic (ar)
English (en)
Inventor
ساكلاني ارفيند
جايكواد باريكشيت
ماني توكارام
ساوانت ساتيش
شارما سوميش
مالبوري نيليش
Original Assignee
بيرامال انتربرايسز ليمتد
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by بيرامال انتربرايسز ليمتد filed Critical بيرامال انتربرايسز ليمتد
Publication of SA113340494B1 publication Critical patent/SA113340494B1/ar

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Reproductive Health (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SA113340494A 2012-04-23 2013-04-23 تركيبة لعلاج اضطرابات أيضية SA113340494B1 (ar)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261636792P 2012-04-23 2012-04-23

Publications (1)

Publication Number Publication Date
SA113340494B1 true SA113340494B1 (ar) 2015-12-24

Family

ID=49482298

Family Applications (1)

Application Number Title Priority Date Filing Date
SA113340494A SA113340494B1 (ar) 2012-04-23 2013-04-23 تركيبة لعلاج اضطرابات أيضية

Country Status (16)

Country Link
US (1) US20150290265A1 (enExample)
EP (1) EP2841080A4 (enExample)
JP (1) JP2015514797A (enExample)
KR (1) KR20150003862A (enExample)
CN (1) CN104244962A (enExample)
AU (1) AU2013254329A1 (enExample)
BR (1) BR112014026326A2 (enExample)
CA (1) CA2870907A1 (enExample)
IL (1) IL235317A0 (enExample)
IN (1) IN2014MN02269A (enExample)
MX (1) MX2014012742A (enExample)
NZ (1) NZ701133A (enExample)
RU (1) RU2014145931A (enExample)
SA (1) SA113340494B1 (enExample)
TW (1) TW201343174A (enExample)
WO (1) WO2013160811A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107405503A (zh) * 2014-12-19 2017-11-28 光环生命科学有限公司 鞣花酸二水合物在药物制剂中调节血糖水平的用途
US11970486B2 (en) 2016-10-24 2024-04-30 Janssen Pharmaceutica Nv Compounds and uses thereof
AU2018205275B2 (en) 2017-01-06 2024-05-02 Janssen Pharmaceutica Nv Methods for the treatment of neurological disorders
US11873298B2 (en) 2017-10-24 2024-01-16 Janssen Pharmaceutica Nv Compounds and uses thereof
RU2020122331A (ru) 2018-01-10 2022-02-10 Брайтсид, Инк. Способ модуляции метаболизма
AU2019238326B2 (en) 2018-03-23 2025-03-06 Janssen Pharmaceutica Nv Compounds and uses thereof
KR20220007845A (ko) 2019-01-24 2022-01-19 유마니티 테라퓨틱스, 인크. 화합물 및 이의 용도
KR20220100896A (ko) 2019-11-11 2022-07-18 브라이트씨드, 인크. 추출물, 소모가능 생성물 및 추출물에서 생물활성 대사산물을 농후화하는 방법
EA202192047A1 (ru) 2019-11-13 2021-12-08 Юманити Терапьютикс, Инк. Соединения и их применение
KR102408566B1 (ko) * 2020-04-09 2022-06-16 대한민국 터미날리아 비아라타 추출물을 이용한 피부 주름 개선용 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005053864A (ja) * 2003-08-06 2005-03-03 Ryukyu Bio Resource Kaihatsu:Kk 糖尿病疾患予防・治療剤
JP2006188486A (ja) * 2004-12-07 2006-07-20 Toyo Shinyaku:Kk 体脂肪蓄積抑制または低減剤
JP2008537539A (ja) * 2005-02-23 2008-09-18 アヴェスタジェン リミテッド 植物抽出物およびそのための方法と使用

Also Published As

Publication number Publication date
TW201343174A (zh) 2013-11-01
JP2015514797A (ja) 2015-05-21
BR112014026326A2 (pt) 2017-06-27
IL235317A0 (en) 2014-12-31
RU2014145931A (ru) 2016-06-20
NZ701133A (en) 2016-08-26
CA2870907A1 (en) 2013-10-31
MX2014012742A (es) 2015-04-08
KR20150003862A (ko) 2015-01-09
EP2841080A4 (en) 2015-11-25
IN2014MN02269A (enExample) 2015-07-24
WO2013160811A1 (en) 2013-10-31
AU2013254329A1 (en) 2014-11-13
US20150290265A1 (en) 2015-10-15
EP2841080A1 (en) 2015-03-04
CN104244962A (zh) 2014-12-24

Similar Documents

Publication Publication Date Title
SA113340494B1 (ar) تركيبة لعلاج اضطرابات أيضية
NZ702663A (en) Nuclear transport modulators and uses thereof
HK1203356A1 (en) Pharmaceutical combinations comprising a thionucleotide analog
MX2018000421A (es) Composiciones de retinoides topicos.
SG10201810888XA (en) Compositions and methods comprising bupropion or related compounds and dextromethorphan
HK1210599A1 (en) Abuse deterrent pharmaceutical compositions for controlled release
WO2014205389A8 (en) Nuclear transport modulators and uses thereof
GB201111485D0 (en) Drug composition and its use in therapy
HK1201828A1 (en) Treatment regimens using multiple pharmaceutical agents
EP2490700A4 (en) EXTERNAL SKIN CARE COMPOSITION COMPRISING SALT AND SUGAR AS ACTIVE INGREDIENTS FOR PREVENTING AND TREATING VAGINOSIS AND USE THEREOF
WO2015056094A3 (en) Pharmaceutical composition comprising a trpa1 antagonist and an analgesic agent
HK1218251A1 (zh) 用拉喹莫德治疗多发性硬化症
MD4563B1 (ro) Produs de comicronizare cu conţinut de acetat de ulipristal
EP4302825A3 (en) Pharmaceutical compositions for treatment of inappetence
GB2525517A (en) Topical preparation for pain relief
MX2020001428A (es) Composiciones de grapiprant y metodos para usar las mismas.
MY160160A (en) Anti-wart pharmaceutical composition and method for treating wart
WO2015063613A3 (en) Inclusion bodies for transdermal delivery of therapeutic and cosmetic agents
IN2014MN01933A (enExample)
BR112014004737A2 (pt) composto de composição de cloridrato de ambroxol e método de preparação do composto
MX366309B (es) Composicion farmaceutica para el tratamiento de inflamacion y dolor.
WO2014116015A3 (ko) 자죽염을 포함하는 알츠하이머병 예방용 조성물 및 자죽염의 제조방법
WO2012108748A3 (ko) 합환피 추출물을 포함하는 뇌암 치료용 조성물 및 화장료 조성물
WO2013038200A3 (en) Neurodevelopmental disorders
WO2012108747A3 (ko) 토목향 추출물을 포함하는 뇌암 치료용 조성물 및 화장료 조성물